Home Blog Page 1189

A 45-year bond: tesa drives innovation and sustainable growth in Singapore

  • Collaboration with impact – Turning partnerships into regional innovation for Singapore’s next phase of growth
  • Innovating for tomorrow – Developing next-gen adhesive solutions that meet future industry needs
  • Building sustainable progress – Advancing circular economy and more sustainable processes across industries

SINGAPORE, Feb. 10, 2026 /PRNewswire/ — tesa, an international manufacturer of innovative adhesive tapes and self-adhesive product solutions, celebrates its 45th anniversary in Singapore this year, marking more than four decades of longstanding commitment and partnership in supporting the nation’s industrial development, skills transformation and sustainability journey.

Since establishing its presence in Singapore in 1981, tesa has grown alongside the country’s transformation into a global hub for business, manufacturing and advanced technologies. Over the last 45 years, tesa has played a pivotal role in enabling precision manufacturing, supporting critical industries and fostering talent development across the Asia-Pacific region through Singapore.

tesa's innovative adhesive solutions support precision manufacturing and advanced technologies across multiple industries in Singapore and the Asia-Pacific region.
tesa’s innovative adhesive solutions support precision manufacturing and advanced technologies across multiple industries in Singapore and the Asia-Pacific region.

A key partner in Singapore’s industrial and manufacturing growth

Backed by over 125 years of experience in the development and manufacture of adhesives and in coating technology, tesa supports advanced manufacturing across multiple industries. Today, tesa’s adhesive and bonding technologies are embedded in products that power life, from smartphones and automotive vehicles to industrial automation systems and packaging.

“Singapore has become a strategic partner in our growth across Asia-Pacific. Over the past 45 years, we have grown together with Singapore’s industrial ecosystem and contributed to nation building through technology, knowledge transfer and long-term partnerships,” said Andreas Gunnestrand, President and Regional Manager, tesa tape Asia-Pacific.

Driving innovation and collaboration across the region through Singapore

Innovation and collaboration are central to tesa’s global success, with Singapore serving as the Asia-Pacific centre of operational best practices across regional offices in Vietnam, Thailand and India, and supporting the development of advanced technologies across key markets. 

Initiatives such as tesa’s new state-of-the-art Debonding on Demand laboratory, opened in partnership with A*STAR, underscore the company’s commitment to accelerating the development of market-ready adhesive solutions, while further strengthening Singapore’s position as a hub for advanced manufacturing and circular economy innovation. tesa’s Debonding on Demand technologies enable clean, damage-free separation which allows manufacturers to disassemble and rework components quickly and efficiently to reduce downtime and maintain cost-effectiveness, while supporting compliance with evolving repair and recycling targets.

In addition, tesa Singapore supports regional customers with technical consulting, customised applications and rapid prototyping capabilities, which helps accelerate product development cycles and improve manufacturing efficiency.

Advancing sustainability and responsible growth

Sustainability is a central pillar of tesa’s global strategy, with Singapore playing an instrumental role in advancing the company’s environmental commitments in the region.

In alignment with the Singapore Green Plan 2030 and broader regional decarbonisation efforts, tesa is focused on reducing emissions, improving resource efficiency and has introduced more sustainable adhesive solutions, including solvent-reduced technologies, bio-based materials and recyclable product designs, to help support customers in achieving their own sustainability goals.

Continuous development into the future

As Singapore enters its next phase of smart manufacturing, electrification and digitalisation, adhesive technologies are playing an increasingly central role in industrial innovation, supporting greater efficiency, performance, and sustainability across industries.

“45 years is both a milestone and a moment of reflection,” said Gunnestrand. “Singapore will continue to serve as a strategic gateway for tesa’s Asia-Pacific growth, supporting key markets across the region and beyond. We are proud of the role we have played in Singapore’s journey, and we remain committed to contributing to the nation’s next phase of growth through innovation, talent development and sustainable progress.”

About tesa SE

As a multinational company, tesa develops innovative adhesive tapes and self-adhesive product solutions for various industries, commercial customers, and end consumers for more than 125 years. There are already more than 7,000 tesa adhesive solutions that help improve the work, products or lives of our customers. Today, the focus is on sustainability and energy-saving processes. tesa invests in the development of environmentally friendly products and solvent-free manufacture processes as well as in the use of renewable energy sources at its locations.

tesa is active in 100 countries and operates plants in Germany, Italy, China, the USA, and in Vietnam. Around three quarters of the tesa Group’s sales (2024: EUR 1.7 billion euro) are generated by applications for industries. Together with its international clients, tesa develops innovations that are customized at product and process level. Already more than 130 tesa tapes may be installed in an electric car and over 70 in a smartphone. In the printing and construction industries, too, tesa is constantly penetrating new segments and countries with its special adhesive tapes. The company generates almost one quarter of its sales with products for end consumers and professional craftsmen. 300 applications, such as the legendary tesafilm®, make life easier or, when it comes to insect protection, even make it a bit more pleasant. tesa counts among the world’s leading manufacturers of adhesive solutions. Since 2001, tesa SE is an independent 100% affiliate of Beiersdorf AG (i.e., NIVEA, Eucerin, la prairie) with approx. 5,400 employees today.

 

MerryLife Biomedical Reports Positive Phase 1 Results and Plans for Global Phase 2 Trial for TML-6, an Oral Multi-Targeted Investigational Therapy for Alzheimer’s Disease

TAINAN, Feb. 10, 2026 /PRNewswire/ — MerryLife Biomedical Inc., a clinical-stage biotechnology company focused on neurodegenerative diseases, today announced positive Phase 1 results for TML-6, its investigational oral therapy for Alzheimer’s disease (AD). The study demonstrated that TML-6 was generally well tolerated with a favorable safety profile, supporting its continued clinical development.

TML-6 is designed to modulate the autolysosomal system and interconnected cellular pathways involved in protein clearance, neuroinflammation, oxidative stress, and aging-related neuronal dysfunction—key biological processes underlying the progression of Alzheimer’s and Parkinson’s diseases (PD). Disruption of these pathways is increasingly recognized as central to neurodegeneration.

Based on these results, MerryLife is preparing to initiate a global Phase 2 program in early Alzheimer’s disease, enrolling individuals with mild cognitive impairment and mild dementia. The study is planned to include approximately 210 participants across the United States, Sweden, and Taiwan. The Phase 2 program will further evaluate safety and tolerability and explore disease-related biomarkers associated with multi-pathway modulation.

In parallel, MerryLife is exploring the potential relevance of TML-6 in Parkinson’s disease, where similar pathological mechanisms contribute to disease progression. The company will present additional preclinical data and clinical development insights on TML-6 at the AD/PD™ 2026 International Conference in Copenhagen on March 19, 2026.

“Neurodegenerative diseases such as Alzheimer’s and Parkinson’s arise from complex, interconnected biological processes that are difficult to address with single-target therapies,” said Dr. Ih-Jen Su, Chief Executive Officer of MerryLife Biomedical. “TML-6 represents a multi-targeted approach with an oral formulation and a favorable safety profile, supporting earlier intervention and the potential to slow disease progression in areas of significant unmet medical need.”

About TML-6
TML-6 is a first-in-class, orally administered, multi-targeted investigational therapy designed to modulate autolysosomal and aging-related pathways implicated in neurodegeneration.

About MerryLife Biomedical
MerryLife Biomedical Inc. is a clinical-stage biotechnology company developing innovative therapies for neurodegenerative diseases by targeting aging-related and disease-relevant biological pathways.

References

  1. Su IJ et al. International Journal of Molecular Sciences. 2020;21:5459.
  2. Su IJ et al. International Journal of Molecular Sciences. 2022;23:556.
  3. Su IJ et al. Formulated TML-6 enhances autolysosome function in neurons and microglias (AD/PD conference, Copenhagen, 2026)

Media Contact
MerryLife Biomedical Inc., 8F B, No. 147, Chung San Rd., Tainan City 710, Taiwan
Email: suihjen0704@tmlbio.com 
Phone: 886-(0)910-902296
Website:  https://www.tmlbio.com/index.php?lang=en 

Medical biotech Ferronova completes enrolment for gastric and oesophageal cancer image-guided surgery trial.

ADELAIDE, Australia, Feb. 10, 2026 /PRNewswire/ — Australian company Ferronova announced today it has completed enrolment of patients for its two-year trial to progress commercialisation of FerroTrace, a novel nanoparticle image-guided surgery solution for hard-to-treat cancers.

The technology is intended to assist surgeons in identifying lymph nodes involved in metastatic spread, thereby enabling targeted removal and reducing the risk of post-surgical recurrence. The study is the first of its kind in which tracer injection to map lymphatic drainage pathways is performed prior to any chemotherapy or radiotherapy. 

Key highlights

  • Patient enrolment has been completed in adults with gastric and oesophageal cancers across five hospital sites in Australia, with a total of 62 patients enrolled, exceeding initial projections.
  • Evaluations and results from the trial are expected to be available in July 2026.
  • The trial follows several smaller first-in-human studies conducted between 2020-2024.
  • FerroTrace addresses an unmet need in surgical guidance for hard-to-treat cancers, with oesophageal and stomach cancers in the world’s top five deadliest cancer types.
  • Stomach and oesophageal cancers affect more than 1.8 million people worldwide each year, with recurrence after surgery occuring in up to 60% of patients. In Australia, three-year survival for oseophageal cancer remains at just 27%.

FerroTrace uses super-paramagnetic iron oxide nanoparticles that bind to cells within lymph nodes. The technology is designed to support more precise surgery, helping surgeons to identify and remove cancer-affected lymph nodes that are frequently missed during standard procedures.

Stewart Bartlett Chief Executive Officer of Ferronova said he was delighted that the trial had completed recruitment.

 “The investigators at the Royal Adelaide, Queen Elizabeth, Flinders, Austin Hospital, and Peter MacCallum Cancer Centre have done an amazing job recruiting patients in a relatively short time. We are looking forward to working with them to complete the final follow-up visits and analyse the data.”

“We hope to give surgeons the opportunity to work with greater diagnostic accuracy and precision, enabling less invasive surgery in some patients, and more precise surgery overall, ensuring all cancer-affected lymph nodes are identified and removed.  This trial is an important step in validating our technology as we move towards commercial availability.”

Appointment of new advisory board member
Ferronova has also appointed a new scientific advisory board member with Ms Aki Smith, a patient advocate, taking up the role this month. Ms Smith founded the US-based charity ‘Hope for Stomach Cancer’ following her father’s diagnosis. The charity provides resources and support to those living with stomach cancer and their families.  

Mr Bartlett welcomed Ms Smith to the advisory board, saying her lived experience will help to inform future trial design and innovations.

“The role of Ms Smith and other members for the scientific advisory board is very important to our company.  Ferronova is deeply committed to finding new solutions for those affected by these aggressive and difficult to treat cancers.

“We are very supportive of patients having a greater voice in the development and evaluation of new treatments, including those involving our technology.”

ABOUT FERRONOVA

Ferronova is an Australian medical technology company headquartered in Adelaide, South Australia. Its mission is to improve treatment options in early stage, complex cancers and increase survival rates with its unique surgical oncology tracer system. Shareholders include Renew Pharmaceuticals Limited (subsidiary of UltraGreen.ai), Uniseed/UniSuper, the South Australian Venture Capital Fund (SAVCF), Artesian Venture Partners, the University of South Australia, Powerhouse Ventures, the University of Wellington in New Zealand, the University of Sydney, PAN Ventures, STOIC Venture Capital, and Perennial Partners Future of Healthcare Fund.  Grant assistance has been provided by the SA Government since 2016 and through the Federal Government’s BioMedTech Horizons Program, operated by MTPConnect and Australian Government CRC-P program. For more information go to: www.ferronova.com.au 

Finmo Appoints Joana Liew as Chief Human Resources Officer

SINGAPORE, Feb. 10, 2026 /PRNewswire/ — Finmo today announced the appointment of Joana Liew as Chief Human Resource Officer (CHRO). Joana joins Finmo’s executive team as the company scales its organisation globally.

Joana will lead Finmo’s global people operations, shaping and executing strategies that support the company’s international expansion. Her remit includes building leadership and performance frameworks, strengthening governance and compliance across regions, aligning talent strategy with business goals, and reinforcing a high-performance, values-led culture as Finmo grows.

David Hanna, Chief Executive Officer at Finmo, says: “Joana brings deep experience building organisations that scale with clarity and discipline. As Finmo grows globally, strong leadership, clear culture, and the right operating foundations matter more than ever. Joana has a proven track record of building those foundations, and she will play a critical role in supporting our next stage of growth.”

With more than 20 years of leadership experience, Joana has worked across FinTech, technology, professional services, retail, marketing communications, property development, and hospitality. She has held senior HR leadership roles at InCorp Global and Cake Group as Chief HR Officer, led organisational design, workforce transformation, and M&A integration across Asia Pacific, and helped build regional HR foundations at TikTok and OKX during periods of rapid expansion. She is also a Certified Executive Coach and has coached more than 50 senior leaders globally.

Joana Liew, Chief Human Resources Officer at Finmo, says: “Finmo is building connected financial intelligence and control for modern CFOs, and that ambition needs strong teams behind it. I’m excited to join Finmo at this stage and help build an organisation that supports scale, develops leaders, and creates an environment where people can do their best work as the business grows.”

About Finmo 

Finmo is a global fintech company transforming how modern finance teams manage cash and treasury operations, backed by PayPal Ventures, Citi Ventures, and Quona Capital.

Founded by David Hanna, Akhil Nigam, Richard Oh, Raj Vimal Chopra, and Thomas Kang, Finmo is purpose-built for today’s cross-border businesses. Our Treasury Management System delivers connected financial intelligence by bringing together data from bank accounts, accounting platforms, ERP systems, and other financial tools, giving CFOs real-time visibility, control, and foresight.

Beyond insights, Finmo empowers action. Through our global payments network and cash management offerings, finance teams can move money, optimize liquidity, and manage FX risk, all within a single intelligent platform. The result: businesses act faster, scale smarter, and operate with confidence in an increasingly interconnected economy.

Trusted by leading enterprises and fintechs, Finmo is licensed in key markets including Singapore, Australia, New Zealand, Canada, the U.S. and the UK. We are committed to building a faster, smarter, and more resilient financial infrastructure for the digital economy.

For more details, visit: https://finmo.net

Media Contact

Zachary Pestana, Salween Group, Finmo@salweengroup.com

PharmaCare Streamlines ANZ Operations and Strengthens Compliance with Manhattan Associates

SYDNEY, Feb. 10, 2026 /PRNewswire/ — Manhattan Associates (NASDAQ: MANH), the global leader in supply chain commerce with unmatched AI capabilities, today announced that PharmaCare, one of Australia’s largest health and wellness companies, has transformed its ANZ distribution network with Manhattan SCALE. The implementation has streamlined receiving workflows by 25%, delivering a 20% increase in daily pick rates, along with automating key TGA-licensed compliance processes.

PharmaCare manages more than 25 iconic brands, including Nature’s Way and Bioglan, and distributes over 1,000 products across pharmacy, grocery and export channels. As the business has expanded from 2009 to six times its size now in 2026, its legacy warehouse environment had become increasingly fragmented, with multiple systems managing radio frequency (RF) networks, voice picking, conveyor control and SSCC labelling.

“We were dealing with multiple systems that didn’t talk to each other, manual data entry for hundreds of pallets a day, and outdated workflows that made even simple tasks complex,” said Craig Dunlop, Head of Distribution and Logistics at PharmaCare. “As we grew, it became harder to manage compliance, throughput and accuracy. We knew we needed a single WMS that could bring everything together and prepare us for the next phase of automation.”

A Unified Platform for Compliance and Growth

Following an evaluation of multiple providers, PharmaCare selected Manhattan SCALE to deliver real-time inventory visibility, full batch and expiry traceability, integrated SSCC labelling and electronic invoicing – all within a single scalable SaaS environment. The move eliminates on-premise maintenance, reduces integration complexity and ensures PharmaCare always receives the latest functionality via continuous updates.

Working closely with Manhattan, PharmaCare also transformed key processes within its Therapeutic Goods Administration (TGA)-licensed DC network. What was previously a two-step receiving and quality-release workflow has now been consolidated into a single electronic process, reducing receiving and equipment time by close to 25% and freeing up warehouse staff for higher-value tasks.

Additionally, the implementation included a new Minimum Life on Receipt (MLOR) allocation program, ensuring all outbound orders meet strict customer shelf-life requirements. This change has eliminated rejected shipments and the costly loop of returns, credits, and re-shipment, while freeing up the equivalent of 1.5 full-time employees from manual checking across office and warehouse teams.

“The MLOR functionality has been a game-changer,” said Dunlop. “Before Manhattan, we were manually managing expiry and shelf-life windows, which was open to human error. Now, the system automatically prevents non-compliant stock from leaving the DC. It’s reduced returns, improved customer confidence, and given us complete peace of mind.”

Measurable Improvements

Within six months of go-live, PharmaCare’s Warriewood distribution centre increased daily pick rates in its pharmacy voice-picking conveyor system by 20%, rising from 10,000 to 12,000 picks per shift with the same staffing levels. The transition to automated SSCC labelling and electronic invoicing has improved accuracy, removed manual keying, and ensured smoother conveyor flow.

“With Manhattan, processes like receiving, quality assurance, and labelling now flow seamlessly, giving teams real-time visibility and freeing them to focus on higher-value tasks rather than repetitive administration,” said Raghav Sibal, Vice President APAC, Manhattan Associates. “PharmaCare’s journey is a great example of how technology and people can evolve together.”

By consolidating three legacy labelling systems into one platform, PharmaCare eliminated manual entry of batch and expiry information and gained true First-Expiry, First-Out (FEFO) capability across all customers and channels.

“We see Manhattan Associates as a long-term partner,” Dunlop concluded. “The system has already exceeded expectations, but more importantly, it’s given us a foundation to keep improving. We’re operating faster, with greater accuracy and confidence than ever before.”

-ends-

ABOUT MANHATTAN ASSOCIATES

Manhattan Associates is a global technology leader, providing supply chain and omnichannel commerce solutions with unmatched AI capabilities. We design, build and offer best-in-class, AI-powered, cloud-based solutions that drive resilience and efficiency for businesses. We enable enterprises to uniquely unify front-end sales with back-end supply chain execution. 

Our commitment to innovation, cloud-native platform and API-first architecture create simpler experiences and faster paths to value for our customers. We empower them to preempt and react to emerging trends and global disruptions with technical expertise and operational confidence, transforming challenges into competitive advantage. For more information, please visit www.manh.com.au 

Johnson & Johnson Launches the First and Only Daily Disposable Multifocal Toric Contact Lens[1] for Astigmatic Adults living with Presbyopia

The brand also expands daily disposable options for astigmatic adults with the launch of ACUVUE® OASYS MAX 1-Day for ASTIGMATISM, bringing pioneering innovation that delivers visual clarity and comfort [+],[**],[2],[3] as vision needs evolve.

SINGAPORE, Feb. 10, 2026 /PRNewswire/ — Today, Johnson & Johnson announced the launch of two new contact lenses in Singapore – ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM – the first and only daily disposable multifocal toric contact lens for people with both astigmatism and presbyopia,[1] and ACUVUE® OASYS MAX 1-Day for ASTIGMATISM. Designed to address the evolving needs of astigmatic patients, both lenses provide exceptional comfort, clarity and stability,[+],[**],[2],[3] plus crisp, clear vision at all distances and in all lighting conditions for presbyopes.[***],[3]

Astigmatism affects about 50% of the population,[4] making it one of the most common vision conditions. It is characterized by imperfections in the curvature of the eye, leading to distorted or blurred vision and visual fatigue. Presbyopia, commonly beginning in the early to mid-40s, is the gradual loss of near vision and it is estimated that up to 2.1 billion people globally will develop presbyopia by 2030 due to our ageing population.[5]

Vision changes are often shaped by more than one factor. In Singapore, studies suggest that close to 60% of adults experience astigmatism alongside presbyopia or other refractive changes,[6] highlighting the varying vision needs that may happen concurrently. These overlapping vision changes affect the quality of how we experience the demands of everyday life – from long workdays, parenting routines to night driving and social activities.

Traditionally, there has been a gap for people with astigmatism when they begin to experience presbyopia. They may have had to make compromises by either switching from daily contact lenses to reusables or layering reading glasses over their contact lenses.

“Astigmatism can cause visual discomfort and eye strain, which is particularly inconvenient for patients at night as they experience light glares, streaks or halos from head- or street-lights. Uncorrected astigmatism makes it tiring to focus for long periods of time, especially in the digital age we’re in. We see an unmet need in both astigmatism and presbyopia as vision needs continue to evolve alongside the way people live, work and interact with the world,” said Ashish Kohli, Vice President, Asia Pacific, Vision Care, Johnson & Johnson.

“With the launch of these two new toric contact lenses for astigmatism in Singapore, we are expanding the ACUVUE® OASYS MAX 1-Day portfolio and are pleased to offer eye care professionals the first and only complete family of daily disposable contact lenses,[###],[1] helping them meet patients’ changing vision needs. This new offering underscores our commitment to delivering tailored solutions that provide all day comfort, clarity and stability for people struggling with astigmatism.[+],[**],[2],[3] 

Regular eye examinations are essential to accurately diagnose vision conditions, enabling eye care professionals to recommend the right solutions while ensuring patients are properly fitted with contact lenses that best support their vision needs.

To learn more about the two new ACUVUE® OASYS MAX 1-Day toric contact lenses or to search for an eye care professional, visit https://www.acuvue.com/en-sg/oasys-max/ 

ACUVUE® OASYS MAX 1-Day MULTIFOCAL for Astigmatism

The ACUVUE® OASYS MAX 1-Day MULTIFOCAL for Astigmatism contact lens is built with the combination of four powerful proprietary technologies[7] which enable its comfort and visual results: EYELID STABILIZED Design helps the lens stay put, so vision is not distorted or blurry when you blink or move your head.[3],[7] PUPIL OPTIMIZED Design helps meet presbyopic vision needs, even as you age and your vision continues to change.[2] TearStable Technology helps keep the lens hydrated, facilitating end of day comfort.[††] [9],[10],[11] Finally, the OptiBlue Light Filter has the highest level of blue-violet light filter, with 60% blue-violet light filtering.[^[‡‡] [7],[3] It has also shown proven performance across its key claims: 

  • 95% of patients report clear vision during daily activities[§],[***],[3]
  • 87% of patients report clear vision while driving at night[§],[***],[3]
  • 92% of patients report comfort throughout the entire day[],[***],[3]

ACUVUE® OASYS MAX 1-Day for Astigmatism 

Featuring a combination of three powerful proprietary technologies[4] – EYELID STABILIZED Design, TearStable Technology, and OptiBlue Light Filter – this contact lens delivers exceptional comfort, clarity and stability[+],[**],[2],[3] and has shown proven performance across its key claims:

  • 96% of patients report stable vision[%],
  • Nearly 99% of patients report clear and reliable vision[+],[3]
  • 89% of patients report all-day comfort[%],[3]

Next-Generation Innovation Tailored for the Astigmatic Eye

Both contact lenses have been developed with a patient-centric design,[*],[7],[12] enabling eye care professionals to provide more tailored solutions for astigmatic patients.

ACUVUE® OASYS MAX 1-Day lenses will now be available in spherical, toric, multifocal, and multifocal toric designs, providing coverage for 96.2% of patients’ eyes.[###],[8] To learn more about the two new ACUVUE® OASYS MAX 1-Day toric contact lenses or to search for an eye care professional, visit https://www.acuvue.com/en-sg/oasys-max/ 

[†]About Vision at Johnson & Johnson

Johnson & Johnson has a deep legacy in developing transformational new products that improve the health of patients’ eyes. We have a bold ambition: Vision Made Possible – improving sight for more than 40 million people each year. Through cutting-edge innovation, expertise in material and optical science, and advanced technologies, we are revolutionizing the way people see and experience the world.

Visit us at jjvision.com, follow @JNJVision on X, Johnson & Johnson Vision on LinkedIn, and @JNJVision on Facebook.  

About Johnson & Johnson  

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more about our MedTech sector’s global scale and deep expertise in cardiovascular, orthopaedics, surgery and vision solutions at https://thenext.jnjmedtech.com. Follow us at @JNJMedTech and on LinkedIn. 

Johnson & Johnson Vision Care, Inc., a Johnson & Johnson Company. 

Important information for contact lens wearers: ACUVUE Contact Lenses are available by prescription only for vision correction. An eye care professional will determine whether contact lenses are right for you. Although rare, serious eye problems can develop while wearing contact lenses. To help avoid these problems, follow the wear and replacement schedule and the lens care instructions provided by your eye doctor. Do not wear contact lenses if you have an eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. If one of these conditions occurs, remove the lens and contact your eye doctor immediately. For more information on proper wear, care and safety, talk to your eye care professional, call 1-800-843-2020, or download the Patient Instruction Guides.

Cautions Concerning Forward-Looking Statements 

This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 related to ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM and ACUVUE OASYS MAX 1-Day for ASTIGMATISM contact lenses. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to: competition, including technological advances, new products and patents attained by competitors; uncertainty of commercial success for new products; the ability of the company to successfully execute strategic plans; impact of business combinations and divestitures; challenges to patents; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; and global health care reforms and trends toward health care cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson’s most recent Annual Report on Form 10-K, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and in Johnson & Johnson’s subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, www.jnj.com, www.investor.jnj.com or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments.

[+] T2B descriptive summaries: n≥144

[*] Versus publicly available information for contact lenses for astigmatism as of July 2023

[**] T2B descriptive summaries: n = 171

[***] n=171

[###] Full/complete family consists of sphere, multifocal, toric and multifocal toric contact lenses

[§] Model-adjusted percent estimate

[¶] T3B descriptive summaries: n=171

[%] T3B descriptive summaries: n ≥ 144

[^] Filtering of HEV light by contact lenses has not been demonstrated to confer any health benefit to the user, including but not limited to retinal protection, protection from cataract progression, reduced eye strain, improved contrast, improved acuity, reduced glare, improved low light vision, or improved circadian rhythm/sleep cycle. The Eye Care Professional should be consulted for more information. 

[††]Versus ACUVUE® OASYS 1-Day, Dailies Total1®, My Day®, Infuse™ and Precision 1®.

[‡‡]Versus publicly available information for standard daily use contact lenses as of December 2023.

© Johnson & Johnson and its affiliates 2026

2026PP05096

 

[1] JJV Data on File 2025, World’s First and Only Daily Disposable Multifocal Toric Contact Lens

[2] JJV Data on file, 2025. Subjective Comparative and Descriptive Standalone Claims for ACUVUE® OASYS MAX 1-Day Contact Lenses for ASTIGMATISM

[3] JJV Data on file, 2024: Subjective Standalone Claims for ACUVUE® OASYS MAX 1-Day MULTIFOCAL Contact Lenses for ASTIGMATISM

[4] Young G, Sulley A & Hunt C. Prevalence of Astigmatism in Relation to Soft Contact Lens Fitting; Eye & CL, 2011: 37: 20-25

[5] Markoulli M, et al. BCLA CLEAR Presbyopia: Epidemiology and impact. Cont Lens Anterior Eye. 2024 Aug;47(4):102157.
[6] Pan CW, Zheng Y-F, Anuar AR, Chew M, Gazzard G, Aung T, Cheng C-Y, Wong TY & Saw S-M. Prevalence of refractive errors in a multiethnic Asian population: the Singapore Epidemiology of Eye Disease Study; Invest Ophthalmol Vis Sci, 2013; 54(4): 2590–2598

[7] JJV Data on File: Technical Description of ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM

[8]JJV Data on file. 2024. SKU Coverage Claims for ACUVUE® OASYS MAX 1-Day and ACUVUE® OASYS MAX 1-Day MULTIFOCAL Brand Contact Lenses.

[9] JJV Data on File 2022. Effect on Tear Film and Evaluation of Visual Artifacts with ACUVUE® OASYS MAX 1-Day Family.

[10] JJV Data on File 2022. JJV Data on File 2022 TearStable™ Technology Definition.

[11] JJV Data on File 2022. Material Properties: 1-DAY ACUVUE® MOIST, 1-DAY ACUVUE® TruEye®, ACUVUE® OASYS 1-Day with HydraLuxe® Technology and ACUVUE® OASYS MAX 1-Day with TearStable™ Technology Brand Contact Lenses and other daily disposable contact lens brands.

[12] JJV Data on file 2022. CSM- ACUVUE® PUPIL OPTIMIZED DESIGN Technology: JJVC contact lenses, design features, and associated benefits.

Spark Math Launches Fully Integrated CPA-Based Peak Performance Classes for Young Math Learners Globally

SINGAPORE, Feb. 10, 2026 /PRNewswire/ — Spark Math (“Spark” or “the Company”), a global leader in interactive small group classes for students from Pre-K through elementary school, has launched its upgraded Peak Performance Class.

The program features a comprehensive enhancement across the Singapore Math curriculum, a teaching team of NUS- and NTU-trained educators, and full integration of the authentic Concrete-Pictorial-Abstract (CPA) approach.


The upgraded program enables students worldwide to access Singapore-style math from home, replicating the pedagogy, instructional flow, and classroom practices traditionally delivered in Singapore schools. The initiative reflects Spark Math’s commitment to expanding access to high-quality mathematics education through proven pedagogy and education technology.

The upgraded Peak Performance Classes centre on the CPA teaching approach, a globally recognised pathway for developing mathematical understanding at the primary level. CPA guides students through a three-stage cognitive progression, beginning with concrete manipulation of objects, advancing to pictorial representation, and culminating in abstract reasoning. The approach is widely adopted across over 70 countries and regions and has been validated by multiple academic studies demonstrating positive effects on learning motivation and achievement.

CPA is fully embedded across lessons in Spark Math classrooms with course design, instructional sequencing, and digital learning tools set up to ensure students consistently experience the CPA progression as they become more familiar and comfortable with mathematical concepts.


Travis Jin, Vice President at Spark Education Group, shared: “Every child deserves the opportunity to learn world-class mathematics. By systematically bringing Singapore’s CPA teaching approach into Spark Math classrooms, we are taking an important step toward making high-quality education more accessible globally and reshaping how students understand mathematics.”

To ensure an authentic learning experience, Spark Math has designed its online classrooms to mirror offline CPA-based instruction. Lessons follow teaching workflows similar to Singapore classroom styles, and interactive digital tools, visual models, and structured problem-solving activities replicate hands-on learning environments. Instructional visuals guide students through concrete operations, pictorial modelling, and abstract deduction, supporting conceptual mastery over traditional rote calculation.

Teaching delivery is supported by a professional instructor team trained in Singapore-style pedagogy. Educators follow unified teaching standards and quality benchmarks, ensuring consistency across classes and markets while maintaining fidelity to the CPA methodology. The launch comes as Singapore-style math and CPA-based instruction continue to gain recognition as reference standards in global mathematics education. As schools and families increasingly seek effective, research-backed approaches to numeracy development, CPA’s emphasis on conceptual understanding and structured thinking has positioned it as a leading instructional framework.


Through the upgraded Peak Performance Classes, Spark Math aims to extend its international teaching footprint while addressing barriers of geography and access. By combining pedagogy grounded in classroom research with education technology, the platform supports broader participation in high-quality learning experiences and promotes equitable access to effective math instruction.

The upgraded Peak Performance Classes are available globally, with additional teaching resources and visual materials designed to support CPA-based learning across different age groups and proficiency levels.

For more information about Spark Math and the Peak Performance Classes, visit https://www.sparkedu.com.

About Spark Education Group

Founded in 2017, Spark Education Group is headquartered in Singapore and has served close to 750,000 students worldwide. Its portfolio of education brands combines research-based pedagogy with technology to improve the learning experience and educational outcomes for students around the world.

InfoComm China Unveils State of China’s Pro AV Market and Opportunities 2026 Industry White-Paper Report

BEIJING, Feb. 10, 2026 /PRNewswire/ — With China’s Pro AV market projected to reach a staggering US$97.5 billion by 2028, Beijing InfoComm China has announced the release of a 25+page white-paper titled ‘A World of Cutting-Edge Pro AV: China’s Pro AV Market Overview & Opportunities’ to help global professionals navigate this massive expansion. The report serves as an educational guide and resource for Pro AV professionals, system integrators, and technology end-users seeking to better understand how China is shaping the global digital landscape and the opportunities to connect with key players.

China’s Pro AV sector is at a pivotal point of transformation, fueled by the convergence of AV, IT, and emerging technologies. This growth engine is underpinned by large-scale digital infrastructure investment, enterprise modernization, and strong demand across education, commercial, and public-sector verticals. Through this white paper, global professionals gain a roadmap to collaborate with innovators driving these advancements.

Further driven by technologies such as AI-enabled automation, real-time collaboration platforms, and interactive display ecosystems are rapidly becoming baseline requirements rather than differentiators. Sustainability is also emerging as a core priority across the Pro AV value chain. Heightened awareness of environmental responsibility, coupled with stricter regulatory requirements and evolving end-user expectations, is accelerating the adoption of sustainable manufacturing practices and environmentally responsible product design. These factors and forces acting in unison is the driving force behind Pro AV and IT innovations in China.

InfoComm China 2026 White-paper Report on China's Pro-AV Market
InfoComm China 2026 White-paper Report on China’s Pro-AV Market

 

InfoComm China 2026 White-Paper Report & Case Studies on Pro-AV
InfoComm China 2026 White-Paper Report & Case Studies on Pro-AV

The report highlights market data, recent government initiatives, as well as Pro AV trends in China from hybrid meetings to integrated solutions, to digital transformation to intelligent service scenarios. In addition, 14 selected case studies from manufacturers and solution providers are illustrated. These include companies who are “export-ready” and seeking new partners with brand features such as global support, customization, and adherence to international standards. Case studies include real-life implementation projects from InfoComm China 2026 exhibitors: AISPEECH, BOLIN TECHNOLOGY, CREATOR, DSPPA, EZPRO, IDSTE, MVIEWER, MUXWAVE, RELACART, SAMPLEX, SEEMILE, SHURE, TAIDEN, and TRACKSTAR. The case examples cover a multitude of sectors from hotels and restaurants to immersive experiences for cultural events, to education, to commercial sectors such as finance, to government sectors such as houses of parliament and implementations, ranging from AI intelligent audio systems for the classrooms to holographic invisible LED screens applied to bank facades.

In line with InfoComm China’s strategic shift toward global integration, the report A World of Cutting-Edge Pro AV: China’s Pro AV Market Overview & Opportunities concludes with additional details on how readers can connect with the export-ready companies illustrated in the report at Beijing InfoComm China 2026. The new International Visitor and Invited Guest programs launched for the event this year also includes tools and resources for overseas visiting professionals to navigate their way to China, through the fair, and efficiently network and conduct business deals. The Invited Guest program offers fully hosted flights to InfoComm China, hotel accommodation, and an array of personalized services to help with sourcing and business-match-making for high-volume technology buyers and decision makers.

For 20 years, Beijing InfoComm China has served as the most professional and influential platform for promoting and expanding China’s global Professional Audio-Visual (Pro AV) industry. Through decades of bringing together manufacturers, solution providers, IT system integrators, and end users of Pro AV, Beijing InfoComm China has become Asia’s premier Hub for Pro AV excellence. Taking place from 15-17 April 2026, at the China National Convention Center (CNCC), the show marks the beginning of a landmark era: the 20th year of the InfoComm China brand, followed by the 20th edition of the tradeshow in 2027. From an exhibition floor hosting over 400 companies and welcoming over 26,000 professional visitors, to a world-class conference lineup of Pro AV industry movers & shakers, to delighting audiences with innovative and immersive themed zones, InfoComm China is where China is shaping the digital forward future.

To download the complimentary report A World of Cutting-Edge Pro AV: China’s Pro AV Market Overview & Opportunities, visit:
https://www.infocomm-china.com/china-pro-av-market-playbook?utm_source=press-release-2&utm_medium=press-release&utm_campaign=ICC-2026-VP-Marketing&utm_vendor=internal 

To learn more about the China Pro-AV Market, InfoComm China and our International Visitor and Hosted Guest programs visit:
https://www.infocomm-china.com/china-pro-av-market?utm_source=press-release-2&utm_medium=press-release&utm_campaign=ICC-2026-VP-Marketing&utm_vendor=internal 

About InfoCommAsia
InfoCommAsia Pte Ltd. extends its influence through three marquee shows: InfoComm Asia; InfoComm China, Beijing; and InfoComm India. Each show features an exhibition that showcases the world’s most cutting-edge and in-demand professional audiovisual and integrated experience technology solutions and a summit that presents learning opportunities. The shows bring together professional audiovisual industry players and top-level decision-makers from across different markets to tap into the vast potential presented by pro AV solutions.

For more information, visit:
infocomm-asia.com | infocomm-china.com | infocomm-india.com 

Global Media Enquiries:
Angie Eng
Director, Marketing, InfoCommAsia Pte Ltd
T: +65 8163 2109
E: media@infocommasia.com; angieeng@infocommasia.com